Advertisement
Advertisement
U.S. markets open in 3 hours 37 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
11.00-0.03 (-0.27%)
At close: 04:00PM EDT
10.94 -0.06 (-0.55%)
Pre-Market: 05:07AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close11.03
Open10.83
Bid10.95 x 28000
Ask10.96 x 3100
Day's Range10.82 - 11.15
52 Week Range6.78 - 11.15
Volume17,074,004
Avg. Volume13,277,177
Market Cap12.216B
Beta (5Y Monthly)1.31
PE Ratio (TTM)N/A
EPS (TTM)-0.56
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 27, 2017
1y Target Est10.73
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
3% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for TEVA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Teva Pharmaceutical Industries
    Analyst Report: Teva Phar Inds LtTeva Pharmaceutical Industries Ltd. is the world's largest generic pharmaceutical manufacturer, with roughly 76 billion tablets and capsules produced annually. The company has over 37,000 employees and a presence in 60 countries. One of every 10 prescriptions in the U.S. is filled with Teva products.
    Rating
    Fair Value
    Economic Moat
    26 days agoArgus Research
View more
Advertisement
Advertisement